Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Xilio Therapeutics, Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-12-08
Purchase
2021-12-10
8:33 pm
Xilio Therapeutics Inc. XLO Bain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Fund II L.P.
Bain Capital Life Sciences Investors II LLC
BCLS II Investco LP
BCLS II Investo (GP) LLC
BCIP Life Sciences Associates LP
10% Owner
42,469 $9.6579 $410,161 2,805,413
(Indirect)
View
2021-10-26
Purchase(A)
2021-11-03
4:20 pm
Xilio Therapeutics Inc. XLO SV7 Impact Medicine Fund LP
SV7 (IMF) GP LLP
10% Owner
625,000 $16 $10,000,000 3,227,264
(Indirect
Direct)
View
2021-10-26
Purchase
2021-10-28
7:15 pm
Xilio Therapeutics Inc. XLO Flynn James E
Deerfield Mgmt L.P.
DEERFIELD PARTNERS L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Mgmt V L.P.
10% Owner
775,000 $16 $12,400,000 1,143,972
(Indirect)
View
2021-10-26
Purchase
2021-10-26
5:30 pm
Xilio Therapeutics Inc. XLO RiverVest Venture Fund IV L.P.
10% Owner
250,000 $16 $4,000,000 1,441,444
(Indirect)
View
2021-10-26
Purchase
2021-10-26
5:04 pm
Xilio Therapeutics Inc. XLO Rock Springs Capital Management LP
Rock Springs Capital LLC
Rock Springs Capital Master Fund LP
Four Pines Master Fund LP
10% Owner
500,000 $16 $8,000,000 1,256,472
(Indirect)
View
2021-10-26
Purchase
2021-10-26
5:02 pm
Xilio Therapeutics Inc. XLO BAY CITY CAPITAL LLC
10% Owner
312,500 $16 $5,000,000 1,129,490
(Indirect)
View
2021-10-26
Purchase
2021-10-26
5:01 pm
Xilio Therapeutics Inc. XLO Atlas Venture Fund XI L.P.
Atlas Venture Opportunity Fund I L.P.
10% Owner
187,500 $16 $3,000,000 735,942
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-01-04
Option Award
2022-01-06
6:48 pm
N/A
2032-01-03
Xilio Therapeutics Inc. XLO Xu Yuan
Director
26,400 $0 26,400
(Direct)
View
2021-12-22(A)
Option Award
2022-01-04
5:32 pm
N/A
2031-12-21
Xilio Therapeutics Inc. XLO Russo Rene
CEO
100,000 $0 100,000
(Direct)
View
2021-12-22
Option Award
2021-12-23
7:06 pm
N/A
2031-12-21
Xilio Therapeutics Inc. XLO Russo Rene
CEO
100,000 $0 100,000
(Direct)
View
2021-10-26
Ownership
2021-11-05
6:26 pm
N/A
N/A
Xilio Therapeutics Inc. XLO Bain Capital Life Sciences Investors LLC
Bain Capital Life Sciences Fund II L.P.
Bain Capital Life Sciences Investors II LLC
BCLS II Investco LP
BCLS II Investo (GP) LLC
BCIP Life Sciences Associates LP
10% Owner
0 $0 2,762,944
(Indirect)
View
2021-10-26(A)
Conversion
2021-11-03
4:20 pm
N/A
N/A
Xilio Therapeutics Inc. XLO SV7 Impact Medicine Fund LP
SV7 (IMF) GP LLP
10% Owner
26,022,654 $0 3,227,264
(Direct)
View
2021-10-26
Conversion
2021-10-28
7:15 pm
N/A
N/A
Xilio Therapeutics Inc. XLO Flynn James E
Deerfield Mgmt L.P.
DEERFIELD PARTNERS L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Mgmt V L.P.
10% Owner
15,129,450 $0 1,143,972
(Indirect)
View
2021-10-26
Conversion
2021-10-28
3:57 pm
N/A
N/A
Xilio Therapeutics Inc. XLO FIL Ltd
See Remark 1
2,296,403 $0 218,705
(Indirect)
View
2021-10-26
Conversion
2021-10-28
3:45 pm
N/A
N/A
Xilio Therapeutics Inc. XLO FMR LLC
See Remark 1
19,754,248 $0 30,780
(Indirect)
View
2021-10-26
Conversion
2021-10-28
12:55 pm
N/A
N/A
Xilio Therapeutics Inc. XLO SV7 Impact Medicine Fund LP
SV7 (IMF) GP LLP
10% Owner
26,022,654 $0 2,602,264
(Direct)
View
2021-10-26
Conversion
2021-10-26
8:31 pm
N/A
N/A
Xilio Therapeutics Inc. XLO TAKEDA PHARMACEUTICAL CO LTD
Takeda Ventures Inc.
10% Owner
2,950,242 $0 1,475,121
(Indirect)
View
2021-10-26
Conversion
2021-10-26
5:30 pm
N/A
N/A
Xilio Therapeutics Inc. XLO RiverVest Venture Fund IV L.P.
10% Owner
1,191,444 $0 1,441,444
(Indirect)
View
2021-10-26
Conversion
2021-10-26
5:06 pm
N/A
N/A
Xilio Therapeutics Inc. XLO Merck KGaA
10% Owner
7,148,664 $0 680,825
(Indirect)
View
2021-10-26
Conversion
2021-10-26
5:04 pm
N/A
N/A
Xilio Therapeutics Inc. XLO Rock Springs Capital Management LP
Rock Springs Capital LLC
Rock Springs Capital Master Fund LP
Four Pines Master Fund LP
10% Owner
9,531,553 $0 1,256,472
(Indirect)
View
2021-10-26
Conversion
2021-10-26
5:02 pm
N/A
N/A
Xilio Therapeutics Inc. XLO BAY CITY CAPITAL LLC
10% Owner
8,578,397 $0 1,129,490
(Indirect)
View
2021-10-26
Conversion
2021-10-26
5:01 pm
N/A
N/A
Xilio Therapeutics Inc. XLO Atlas Venture Fund XI L.P.
Atlas Venture Opportunity Fund I L.P.
10% Owner
26,728,062 $0 735,942
(Indirect)
View
2021-10-26
Option Award
2021-10-26
5:01 pm
N/A
2030-07-22
Xilio Therapeutics Inc. XLO Clancy Paul J
Director
109,561 $0 109,561
(Direct)
View
2021-10-26
Conversion
2021-10-26
4:51 pm
N/A
N/A
Xilio Therapeutics Inc. XLO Alexandria Venture Investments LLC
10% Owner
1,747,449 $0 166,423
(Direct)
View
2021-10-21
Option Award
2021-10-25
5:18 pm
N/A
2031-10-20
Xilio Therapeutics Inc. XLO Russo Rene
CEO
10% Owner
50,041 $0 50,041
(Direct)
View
2021-10-21
Option Award
2021-10-25
5:18 pm
N/A
2031-10-20
Xilio Therapeutics Inc. XLO Ross Michael Jay
Director
26,400 $0 26,400
(Direct)
View
2021-10-21
Option Award
2021-10-25
5:17 pm
N/A
2031-10-20
Xilio Therapeutics Inc. XLO Huber Martin H. Jr.
President of R & D and CMO
157,058 $0 157,058
(Direct)
View
2021-10-21
Option Award
2021-10-25
5:16 pm
N/A
2031-10-20
Xilio Therapeutics Inc. XLO Giovine Salvatore
CFO
28,755 $0 28,755
(Direct)
View
2021-10-21
Ownership
2021-10-22
8:16 pm
N/A
N/A
Xilio Therapeutics Inc. XLO Williams John Charles
10% Owner
0 $0 100,080
(Direct)
View
2021-10-21
Ownership
2021-10-21
9:36 pm
N/A
N/A
Xilio Therapeutics Inc. XLO Flynn James E
Deerfield Mgmt L.P.
DEERFIELD PARTNERS L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Mgmt V L.P.
10% Owner
0 $0 1,512,944
(Indirect)
View
2021-10-21
Ownership
2021-10-21
9:00 pm
N/A
N/A
Xilio Therapeutics Inc. XLO FIL Ltd
10% Owner
0 $0 218,705
(Indirect)
View
2021-10-21
Ownership
2021-10-21
8:59 pm
N/A
N/A
Xilio Therapeutics Inc. XLO Alexandria Venture Investments LLC
10% Owner
0 $0 166,423
(Direct)
View
2021-10-21
Ownership
2021-10-21
8:53 pm
N/A
N/A
Xilio Therapeutics Inc. XLO Estate of Ulrich Rodeck
10% Owner
0 $0 100,080
(Direct)
View
2021-10-21
Ownership
2021-10-21
8:52 pm
N/A
N/A
Xilio Therapeutics Inc. XLO CLACKSON TIMOTHY P
10% Owner
0 $0 111,751
(Direct)
View
2021-10-21
Ownership
2021-10-21
8:52 pm
N/A
N/A
Xilio Therapeutics Inc. XLO TOMLINSON SIMON M
10% Owner
0 $0 131,117
(Direct)
View
2021-10-21
Ownership
2021-10-21
8:51 pm
N/A
N/A
Xilio Therapeutics Inc. XLO Rock Springs Capital Management LP
Rock Springs Capital LLC
Rock Springs Capital Master Fund LP
Four Pines Master Fund LP
10% Owner
0 $0 907,766
(Indirect)
View
2021-10-21
Ownership
2021-10-21
8:50 pm
N/A
N/A
Xilio Therapeutics Inc. XLO Merck KGaA
10% Owner
0 $0 680,825
(Indirect)
View
2021-10-21
Ownership
2021-10-21
8:49 pm
N/A
N/A
Xilio Therapeutics Inc. XLO BAY CITY CAPITAL LLC
10% Owner
0 $0 816,990
(Indirect)
View
2021-10-21
Ownership
2021-10-21
8:49 pm
N/A
N/A
Xilio Therapeutics Inc. XLO FMR LLC
10% Owner
0 $0 1,907,670
(Indirect)
View
2021-10-21
Ownership
2021-10-21
8:48 pm
N/A
N/A
Xilio Therapeutics Inc. XLO Atlas Venture Fund XI L.P.
Atlas Venture Associates XI L.P.
Atlas Venture Associates XI LLC
Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
10% Owner
0 $0 2,571,844
(Indirect)
View
2021-10-21
Ownership
2021-10-21
8:45 pm
N/A
N/A
Xilio Therapeutics Inc. XLO Russo Rene
CEO
10% Owner
0 $0 1,048,804
(Direct)
View
2021-10-21
Ownership
2021-10-21
8:45 pm
N/A
2031-08-22
Xilio Therapeutics Inc. XLO Bonstein Sara
Director
0 $0 53,213
(Direct)
View
2021-10-21
Ownership
2021-10-21
8:44 pm
N/A
2031-03-28
Xilio Therapeutics Inc. XLO Giovine Salvatore
CFO
0 $0 233,596
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, Next